Novel coronavirus pneumonia research is intensive. 37 projects registered for clinical application, and radcivir started phase 3

Since the outbreak of novel coronavirus pneumonia in Wuhan, it has become the most urgent task to find effective drugs for the treatment of epidemic diseases In January 30th, novel coronavirus pneumonia was relieved in the United States in January 30th, when a new confirmed crown pneumonia was diagnosed in the United States in the new medical journal of England Bring hope to the domestic patients On February 4, the national health and Health Commission held a press conference, and the readcivir purchased by the Institute of medicine of the Chinese Academy of Medical Sciences from Gilead has arrived in China Phase 3 clinical start of Reed civir, 761 patients in the group Novel coronavirus infection was launched in the Wuhan golden Yin Tan Hospital in the afternoon of February 5th The team began to enter clinical trials According to CCTV news reports, 761 cases were enrolled, among which 308 were mild and moderate, and 453 were severe 453 of the critically ill patients were given a randomized double blind method for drug testing Wang Chen, Cao Bin, and the team of remdesivir, 2019 It is reported that radcivir is a nucleotide analogue prodrug, which is under development by Gilead company for Ebola virus At present, ridcivir of Gilead company has completed a phase II clinical trial in Australia to prove that the drug can inhibit the spread and replication of Ebola virus, and it has been proved that it has activity on the viral pathogens of SARS and mers These viruses belong to novel coronavirus and are similar to the 2019-nCoV coronavirus The novel coronavirus pneumonia patients who have been taken out of the US have been effective after taking the drug The first phase and two phase clinical trials were directly introduced into the 3 phase clinical study According to the phase III clinical trial plan of remdesivir, the trial was officially started on February 5, the preliminary completion will be on April 10, 2020, and the final completion is expected to be on April 27 Undoubtedly, the hope turning point of the epidemic has already appeared R & D breakthrough, 37 projects have been registered in addition to radcivir, domestic research also found chloroquine phosphate, fabiravir, as well as a number of Chinese patent medicines with antiviral activity on the market According to the novel coronavirus pneumonia clinical data progress database, the new Reed crown virus clinical trial database, which has just opened, has registered 37 new coronavirus clinical data records as of February 6th In addition, according to the progress of international clinical trials of new coronavirus, there are also three new registration information, one of which has entered clinical phase 4 New crown virus international clinical trial progress, more details of the latest progress of clinical research of new crown virus, please pay attention to WeChat official account (ID:yaozh008), click on the epidemic map, query data, or click on the link to visit: https://kfy.yaozh.com/ 37 Statement: this opinion only represents the author, not the position of yaozhi.com, welcome to exchange and supplement in the message area; if you need to reprint, please be sure to indicate the author and source of the article.